Genetic testing for children with fanconi anemia
Part of Blood & lymphatic, Genetic & congenital, Hormones & metabolism clinical trials.
This study uses advanced genetic testing to look at the DNA of children with Fanconi anemia and their parents. The goal is to learn more about the genetic causes of the condition, which might help guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must have a confirmed diagnosis of Fanconi anemia.
- Your child must be treated at the Blood Disease Hospital (likely in China).
- Your child must be under 18 years old (the study says 'children').
- You must be able to provide consent for your child to join the study.
- The study is taking place between August 2010 and July 2011.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests giving a bone marrow transplant to a fetus diagnosed with Fanconi anemia while still in the womb. The goal is to help the baby's body make healthy blood cells before birth, potentially reducing complications after birth.
This study looks at how squamous cell carcinoma (a type of cancer) naturally develops over time in people with Fanconi anemia. It may help doctors better recognize warning signs and plan care in the future.
This Phase 2 study tests a stem cell transplant approach using adjusted chemotherapy doses for people with Fanconi anemia. It may help replace damaged bone marrow and treat blood problems like severe aplastic anemia, MDS, or leukemia.
This is a follow-up study for patients who previously received RP-L102, an experimental gene therapy designed to treat Fanconi anemia by fixing a faulty gene. The study tracks how well the treatment continues to work and watches for any long-term side effects.
This study looks at why people with inherited bone marrow failure syndromes (rare genetic conditions affecting blood cell production) have higher cancer risk. Researchers want to understand the genetic and medical factors that increase cancer likelihood, which could help doctors monitor and protect affected patients and their families.
This study looks at genetic (DNA) factors that may contribute to certain blood disorders. You may be invited if you or a close family member is receiving care for a blood condition like MDS or MPN, and the study also includes related relatives.
Hear when a new Fanconi Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.